Download this eBook
According to Grandview Research, the hybrid and decentralized clinical trial (DCT) market will be worth more than 12 billion dollars by 2030. Sparked by the COVID-19 pandemic of 2020, the rapid ascent of patient centered technology and the digital and decentralized trials they’ve spawned has forever changed the landscape of clinical conduct.
Sponsors are increasingly turning to DCT platforms in alignment with the rise of Life Science and Software-as-a-Service (SaaS) solutions. However, the real potential of DCT lies in its widespread adoption, rather than its use in a single study.
Topics covered include:
Offered Free by: Medable
See All Resources from: Medable
This download should complete shortly. If the resource doesn't automatically download, please, click here.